Here, we reported that oncoprotein cancerous inhibitor of protein phosphatase 2A (CIP2A) inhibited glycolysis and promoted oxidative metabolism in NSCLC cells. The gene discussed is CIP2A; the disease is non-small cell lung carcinoma.